HIV and Hepatitis C Risk among Tajik Migrant Workers Who Inject Drugs in Moscow

Mary Ellen Mackesy-Amiti, Judith A Levy, Mahbatsho Bahromov, Jonbek Jonbekov, Casey M Luc, Mary Ellen Mackesy-Amiti, Judith A Levy, Mahbatsho Bahromov, Jonbek Jonbekov, Casey M Luc

Abstract

The human immunodeficiency virus (HIV) epidemic in Eastern Europe and Central Asia continues to grow with most infections occurring in high-risk groups including people who inject drugs and their sexual partners. Labor migrants from this region who inject drugs while in Russia are at especially high HIV risk. Male Tajik migrant workers who inject drugs in Moscow (N = 420) were interviewed prior to a randomized trial of the Migrants' Approached Self-Learning Intervention in HIV/AIDS (MASLIHAT) peer-education HIV-prevention intervention. Participants were interviewed about their sex and drug use behavior and tested for HIV and hepatitis C (HCV) prior to the intervention. Only 17% had ever been tested for HIV. Over half of the men reported injecting with a previously used syringe in the past month, and substantial proportions reported risky sexual behavior. Prevalence rates of HIV (6.8%) and HCV (2.9%) were elevated, although lower than expected when compared to estimates of prevalence among people who inject drugs at the national level in Tajikistan. Risk behavior in diaspora varied across the men's regional area of origin in Tajikistan and occupation in Moscow, with HIV prevalence rates highest among those working at the bazaars. Evidence-based prevention approaches and messaging that specifically address the drug- and sex-related risk behavior of migrants with varying backgrounds are needed.

Keywords: HIV; Tajik migrant worker; hepatitis C; injection drug use; peer networks; risk behavior.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Map of Tajikistan.
Figure 2
Figure 2
HIV and HCV test results by recruitment venue.

References

    1. UNAIDS Global HIV & AIDS Statistics—2022 Fact Sheet. 2022. [(accessed on 17 August 2022)]. Available online: .
    1. UNAIDS . In Danger: UNAIDS Global AIDS Update 2022. Joint United Nations Programme on HIV/AIDS; Geneva, Switzerland: 2022.
    1. UNAIDS . Prevention Gap Report. Joint United Nations Programme on HIV/AIDS; Geneva, Switzerland: 2016.
    1. Federal Scientific and Methodological Center for AIDS Prevention and Control, “BИЧ-инфeкция в Poccийcкoй Фeдepaции нa 31.12.2021” [HIV Infection in the Russian Federation as of December 31, 2021] (PDF) 2021. [(accessed on 1 May 2023)]. Available online: .
    1. UNAIDS. International Organization for Migration Migration and AIDS. Int. Migr. 1998;36:445–468. doi: 10.1111/1468-2435.00056.
    1. Del Amo J., Bröring G., Hamers F.F., Infuso A., Fenton K. Monitoring HIV/AIDS in Europe’s migrant communities and ethnic minorities. AIDS. 2004;18:1867–1873. doi: 10.1097/00002030-200409240-00002.
    1. El-Bassel N., Gilbert L., Shaw S.A., Mergenova G., Terlikbayeva A., Primbetova S., Ma X., Chang M., Ismayilova L., Hunt T., et al. The Silk Road Health Project: How mobility and migration status influence HIV risks among male migrant workers in Central Asia. PLoS ONE. 2016;11:e0151278. doi: 10.1371/journal.pone.0151278.
    1. World Health Organization (WHO) Epidemiological Factsheet: Tajikistan. Joint UN Programme on HIV/AIDS (UNAIDS); Geneva, Switzerland: 2010.
    1. United Nations Office on Drugs and Crime . Opiate Flows through Northern Afghanistan and Centre Asia: A Threat Assessment. UNODC; Geneva, Switzerland: 2012.
    1. Zabransky T., Mravcik V., Talu A., Jasaitis E. Post-Soviet Central Asia: A summary of the drug situation. Int. J. Drug Policy. 2014;25:1186–1194. doi: 10.1016/j.drugpo.2014.05.004.
    1. World Bank Prevalence of HIV, Total (% of Population ages 15–49)—Tajikistan. [(accessed on 5 May 2023)]. Available online: .
    1. Pommersheim J.M. How the U.S. Government and Tajikistan Partner to Fight HIV/AIDS [Opinion] [(accessed on 1 February 2023)]; Available online:
    1. Burchell A.N., Calzavara L.M., Orekhovsky V., Ladnaya N.N. Characterization of an emerging heterosexual HIV epidemic in Russia. Sex. Transm. Dis. 2008;35:807–813. doi: 10.1097/OLQ.0b013e3181728a9e.
    1. Stuikyte R., IBarbosa, Kazatchkine M. Getting to grips with the HIV epidemic in Russia. Curr. Opin. HIV AIDS. 2019;14:381–386. doi: 10.1097/COH.0000000000000573.
    1. UNAIDS UNAIDS Global AIDS Monitoring. 2022. [(accessed on 30 August 2022)]. Available online:
    1. Federal Scientific and Methodological Center for the Prevention and Control of AIDS in Russia HIV Infection: Informational Bulletin #47. [(accessed on 1 May 2023)]. Available online: .
    1. Weine S.M., Kashuba A.B. Labor migration and HIV risk: A systematic review of the literature. AIDS Behav. 2012;16:1605–1621. doi: 10.1007/s10461-012-0183-4.
    1. Kashnitsky D., Richter J.M. ‘In Short, We Will Deport You’: Disrupted temporalities of migrants with HIV in Russia. Glob. Public Health. 2022;17:2841–2853. doi: 10.1080/17441692.2021.2002923.
    1. UNAIDS Listening to the Voices of Migrants Living with HIV in the Russian Federation. [(accessed on 17 August 2022)]. Available online: .
    1. Bromberg D.J., Tate M.M., Alaei K., Karimov S., Saidi D., Alaei A. Association between time spent in the Russian Federation and late presentation for HIV among Tajikistani migrants. BMC Public Health. 2020;20:1379. doi: 10.1186/s12889-020-09434-6.
    1. Guillon M., Celse M., Geoffard P.-Y. Economic and public health consequences of delayed access to medical care for migrants living with HIV in France. Eur. J. Health Econ. 2018;19:327–340. doi: 10.1007/s10198-017-0886-6.
    1. Ingabire P.M., Semitala F., Kamya M.R., Nakanjako D. Delayed antiretroviral therapy (ART) initiation among hospitalized adults in a resource-limited settings: A challenge to the global target of ART for 90% of HIV-infected individuals. AIDS Res. Treat. 2019;2019:1832152. doi: 10.1155/2019/1832152.
    1. Golobof A., Weine S., Bahromov M., Luo J. The roles of labor migrants’ wives in HIV/AIDS risk and prevention in Tajikistan. AIDS Care. 2011;23:91–97. doi: 10.1080/09540121.2010.498859.
    1. HIV/AIDS Prevention Research Synthesis Project . Self-Help in Eliminating Life-Threatening Diseases (SHIELD) in Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2020.
    1. Levy J.A., Mackesy-Amiti M.E., Bakhromov M., Jonbekov J., Latkin C.A. A network-based HIV prevention intervention for Tajik migrant workers who inject drugs. AIDS Behav. 2022;26:719–727. doi: 10.1007/s10461-021-03431-5.
    1. Zhang X., Rhoads N., Rangel M.G., Hovell M.F., Magis-Rodriguez C., Sipan C.L., Gonzalez-Fagoaga J.E., Martínez-Donate A.P. Understanding the impact of migration on HIV risk: An analysis of Mexican migrants’ sexual practices, partners, and contexts by migration phase. AIDS Behav. 2017;21:935–948. doi: 10.1007/s10461-016-1622-4.
    1. Giorgio M., Townsend L., Zembe Y., Cheyip M., Guttmacher S., Carter R., Mathews C. HIV prevalence and risk factors among male foreign migrants in Cape Town, South Africa. AIDS Behav. 2017;21:949–961. doi: 10.1007/s10461-016-1521-8.
    1. Olawore O., Tobian A.A.R., Kagaayi J., Bazaale J.M., Nantume B., Kigozi G., Nankinga J., Nalugoda F., Nakigozi G., Kigozi G., et al. Migration and risk of HIV acquisition in Rakai, Uganda: A population-based cohort study. Lancet HIV. 2018;5:e181–e189. doi: 10.1016/S2352-3018(18)30009-2.
    1. Dias S., Gama A., Loos J., Roxo L., Simões D., Nöstlinger C. The role of mobility in sexual risk behaviour and HIV acquisition among sub-Saharan African migrants residing in two European cities. PLoS ONE. 2020;15:e0228584. doi: 10.1371/journal.pone.0228584.
    1. Alessi E.J., Kahn S., Giwa S., Cheung S. ‘Those tablets, they are finding an empty stomach’: A qualitative investigation of HIV risk among sexual and gender minority migrants in Cape Town, South Africa. Ethn. Health. 2022;27:800–816. doi: 10.1080/13557858.2020.1817342.
    1. Guerra-Ordoñez J.A., Benavides-Torres R.A., Zapata-Garibay R., Ruiz-Cerino J.M., Ávila-Alpirez H., Salazar-Barajas M.E. Percepción de riesgo para VIH y sexo seguro en migrantes de la frontera norte de México. Rev. Int. 2022;20:80–85. doi: 10.1016/j.androl.2020.10.010.
    1. Poletaev D.V. Life and health of labor migrants from Central Asia in Russia in the context of the COVID-19 pandemic. Popul. Econ. 2022;6:83–106. doi: 10.3897/popecon.6.e90370.
    1. Sharifzoda K. Why Is Kazakhstan a Growing Destination for Central Asian Migrant Workers? The Diplomat. Epub: 13 June 13 2019. [(accessed on 20 February 2023)]. Available online:
    1. Deryabina A.P., El-Sadr W.M. Optimizing HIV prevention and treatment outcomes for persons with substance use in Central Asia: What will it take? Curr. Opin. HIV AIDS. 2019;14:374–380. doi: 10.1097/COH.0000000000000565.
    1. Saunders J.B., Aasland O.G., Babor T.F., De La Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88:791–804. doi: 10.1111/j.1360-0443.1993.tb02093.x.
    1. El-Bassel N., Marotta P.L. Alcohol and sexual risk behaviors among male Central Asian labor migrants and non-migrants in Kazakhstan: Implications for HIV prevention. AIDS Behav. 2017;21:183–192. doi: 10.1007/s10461-017-1918-z.
    1. Bromberg D.J., Tate M.M., Alaei A., Rozanova J., Karimov S., Saidi D., Alaei K., Altice F.L. “Who are you and what are you doing here?”: Social capital and barriers to movement along the HIV care cascade among Tajikistani migrants with HIV to Russia. AIDS Behav. 2021;25:3115–3127. doi: 10.1007/s10461-021-03359-w.
    1. Degenhardt L., Peacock A., Colledge S., Leung J., Grebely J., Vickerman P., Stone J., Cunningham E.B., Trickey A., Dumchev K., et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. Lancet Glob. Health. 2017;5:e1192–e1207. doi: 10.1016/S2214-109X(17)30375-3.
    1. Jarlais D.C.D., Feelemyer J.P., Modi S.N., Arasteh K., Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124:95–107. doi: 10.1016/j.drugalcdep.2011.12.020.
    1. UNAIDS . The Gap Report. Joint United Nations Programme on HIV/AIDS (UNAIDS); Geneva, Switzerland: 2014.
    1. Kashnitsky D. The Russian HIV residence ban and state control of migration. J. Public Health Policy. 2020;41:453–463. doi: 10.1057/s41271-020-00242-1.
    1. Gorina E., Agadjanian V., Zotova N. Migrant women’s economic success in Russia: Objective reality and subjective assessment. J. Ethn. Migr. Stud. 2018;44:1584–1603. doi: 10.1080/1369183X.2017.1333410.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner